GLADSTONE AIREWELE to Male
This is a "connection" page, showing publications GLADSTONE AIREWELE has written about Male.
Connection Strength
0.105
-
Intermittent or uneven daily administration of low-dose hydroxyurea is effective in treating children with sickle cell anemia in Angola. Pediatr Blood Cancer. 2018 12; 65(12):e27365.
Score: 0.020
-
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043). Br J Haematol. 2011 Apr; 153(1):92-104.
Score: 0.012
-
Erythrocytapheresis in children with sickle cell disease and acute chest syndrome. Pediatr Blood Cancer. 2009 Dec; 53(6):1060-3.
Score: 0.011
-
Management of nutritional iron deficiency anemia for young children in the emergency department. Pediatr Blood Cancer. 2023 03; 70(3):e30181.
Score: 0.007
-
Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol. 2001 Jan; 20(1):75-86.
Score: 0.006
-
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease. Am J Hematol. 2020 09; 95(9):E242-E244.
Score: 0.006
-
Incidental findings on brain magnetic resonance imaging of children with sickle cell disease. Pediatrics. 2010 Jul; 126(1):53-61.
Score: 0.006
-
Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst. 1998 Apr 01; 90(7):543-4.
Score: 0.005
-
Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL? Sickle Cell Disease Module. Health Qual Life Outcomes. 2017 Jun 12; 15(1):124.
Score: 0.005
-
A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola. J Pediatr. 2015 Dec; 167(6):1314-9.
Score: 0.004
-
Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients. Am J Clin Pathol. 2015 Aug; 144(2):263-70.
Score: 0.004
-
A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children. Blood. 2015 Oct 01; 126(14):1651-7.
Score: 0.004
-
Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med. 2014 Aug 21; 371(8):699-710.
Score: 0.004
-
Tuberculosis in pediatric oncology and bone marrow transplantation patients. Pediatr Blood Cancer. 2014 Aug; 61(8):1484-5.
Score: 0.004
-
Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood. 2012 Apr 19; 119(16):3684-90.
Score: 0.003
-
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol. 2010 Jun; 11(6):543-52.
Score: 0.003
-
Glutathione S-transferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res. 2004 Apr 15; 10(8):2618-25.
Score: 0.002